New Inhaler Helps Kids Breathe Easier

Quick Smiles:

• First trial finds a 2-in-1 inhaler cuts children’s asthma attacks by 45%.
• Study confirms the safety of the combined-inhaler for children as young as five.
• New results could lead to updated asthma treatment guidelines for kids worldwide.

Groundbreaking research suggests that millions of children with asthma may soon benefit from a more effective inhaler option. A recent international study compared a new 2-in-1 inhaler with the standard salbutamol treatment and found significant improvements in outcomes for young patients.

The year-long CARE study involved 360 children in New Zealand who were randomly assigned to use either the combined budesonide-formoterol inhaler or salbutamol for on-demand relief. The 2-in-1 inhaler reduced asthma attacks by an average of 45%, meaning 18 fewer attacks per 100 children with mild asthma each year when switching treatments.

Importantly, researchers noted no differences in safety measures like growth or lung function between the two groups. The study’s success may encourage updates to current guidelines, aligning children’s asthma care with adult recommendations.

“FOR THE FIRST TIME, WE HAVE DEMONSTRATED THAT THE BUDESONIDE-FORMOTEROL 2-IN-1 INHALER, USED AS NEEDED FOR SYMPTOM RELIEF, CAN SIGNIFICANTLY REDUCE ASTHMA ATTACKS IN CHILDREN WITH MILD ASTHMA,” said Dr Lee Hatter, lead author.

“Implementing these findings could be transformative for asthma management on a global scale,” added Professor Richard Beasley.

Professor Andrew Bush, a respiratory pediatrician and study co-author, shared, “I’m so pleased that we’ve been able to prove that an inhaler that significantly reduces attacks—already a game-changer for adults—is safe for children with mild asthma as young as five.”

This discovery brings renewed hope to families everywhere.

For more cheerful updates, share this story and stay tuned to Healthy Happy News!

Source